RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > It’s the Law: Impact of the New Vertical Block Exemption Regulation on Healthcare Commercial Agreem

It’s the Law: Impact of the New Vertical Block Exemption Regulation on Healthcare Commercial Agreements in Europe

Posted 01 August 2010 | By

On 1 June 2010, the legal framework for commercial agreements in the EU changed. The new Vertical Block Exemption Regulation No. 330/2010, along with the associated guidelines, came into force.1 This article highlights the most important amendments and addresses their potential impact on current and future business activities of US companies active in the healthcare sector in the EU.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.